1 - 25 of 110 results for author:"Watson P." in Literature citations
Results Customize
› Repeat search in UniProtKB (2,267)
| Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program. Florez J.C., Jablonski K.A., McAteer J.B., Franks P.W., Mason C.C., Mather K., Horton E., Goldberg R., Dabelea D., Kahn S.E. et al. PLoS ONE 7:e44424-e44424(2012) · Mapped (2) |
| Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancers. Stratford A.L., Reipas K., Hu K., Fotovati A., Brough R., Frankum J., Takhar M., Watson P., Ashworth A., Lord C.J. et al. Stem Cells 30:1338-1348(2012) · Mapped (2) |
| Structural characterization and oligomerization of the TssL protein, a component shared by bacterial type VI and type IVb secretion systems. Durand E., Zoued A., Spinelli S., Watson P.J., Aschtgen M.S., Journet L., Cambillau C., Cascales E. J. Biol. Chem. 287:14157-14168(2012) · UniProtKB (1) · Mapped (1) |
| Structure of HDAC3 bound to co-repressor and inositol tetraphosphate. Watson P.J., Fairall L., Santos G.M., Schwabe J.W. Nature 481:335-340(2012) · Mapped (6) |
| A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion. Rao V.H., Kandel A., Lynch D., Pena Z., Marwaha N., Deng C., Watson P., Hansen L.A. Oncogene 31:2888-2898(2012) · Mapped (8) |
| Estrogen receptor alpha phosphorylated at tyrosine 537 is associated with poor clinical outcome in breast cancer patients treated with tamoxifen. Skliris G.P., Nugent Z., Watson P.H., Murphy L.C. Horm Cancer 1:215-221(2010) · Mapped (58) |
| Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression. Turner D.P., Findlay V.J., Moussa O., Semenchenko V.I., Watson P.M., LaRue A.C., Desouki M.M., Fraig M., Watson D.K. Prostate 71:1723-1735(2011) · Mapped (1) |
| Structural basis for the assembly of the SMRT/NCoR core transcriptional repression machinery. Oberoi J., Fairall L., Watson P.J., Yang J.C., Czimmerer Z., Kampmann T., Goult B.T., Greenwood J.A., Gooch J.T., Kallenberger B.C. et al. Nat. Struct. Mol. Biol. 18:177-184(2011) · UniProtKB (1) · Mapped (7) |
| Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo. Kemp E.H., Emhemad S., Akhtar S., Watson P.F., Gawkrodger D.J., Weetman A.P. Exp. Dermatol. 20:35-40(2011) · Mapped (19) |
| Clinical significance of estrogen receptor phosphorylation. Murphy L.C., Seekallu S.V., Watson P.H. Endocr. Relat. Cancer 18:R1-14(2011) · Mapped (58) |
| Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Kendrick A.A., Choudhury M., Rahman S.M., McCurdy C.E., Friederich M., Van Hove J.L., Watson P.A., Birdsey N., Bao J., Gius D. et al. Biochem. J. 433:505-514(2011) · Mapped (4) |
| CREB downregulation in vascular disease: a common response to cardiovascular risk. Schauer I.E., Knaub L.A., Lloyd M., Watson P.A., Gliwa C., Lewis K.E., Chait A., Klemm D.J., Gunter J.M., Bouchard R. et al. Arterioscler. Thromb. Vasc. Biol. 30:733-741(2010) · Mapped (11) |
| S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer. West N.R., Watson P.H. Oncogene 29:2083-2092(2010) · Mapped (8) |
| Structural and functional characterization of a triple mutant form of S100A7 defective for Jab1 binding. West N.R., Farnell B., Murray J.I., Hof F., Watson P.H., Boulanger M.J. Protein Sci. 18:2615-2623(2009) · Mapped (1) |
| Identification and characterization of binding sites on S100A7, a participant in cancer and inflammation pathways. Leon R., Murray J.I., Cragg G., Farnell B., West N.R., Pace T.C., Watson P.H., Bohne C., Boulanger M.J., Hof F. Biochemistry 48:10591-10600(2009) · Mapped (1) |
| Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients. Yan Y., Skliris G.P., Penner C., Chooniedass-Kothari S., Cooper C., Nugent Z., Blanchard A., Watson P.H., Myal Y., Murphy L.C. et al. Breast Cancer Res. 11:R67-R67(2009) · Mapped (2) |
| Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. Milne K., Kobel M., Kalloger S.E., Barnes R.O., Gao D., Gilks C.B., Watson P.H., Nelson B.H. PLoS ONE 4:e6412-e6412(2009) · Mapped (12) |
| Organisation of human ER-exit sites: requirements for the localisation of Sec16 to transitional ER. Hughes H., Budnik A., Schmidt K., Palmer K.J., Mantell J., Noakes C., Johnson A., Carter D.A., Verkade P., Watson P. et al. J. Cell. Sci. 122:2924-2934(2009) · Mapped (13) |
| Detecting BRCA2 protein truncation in tissue biopsies to identify breast cancers that arise in BRCA2 gene mutation carriers. Watson P., Lieberman R., Snyder C., Clark V.J., Lynch H.T., Holt J.T. J. Clin. Oncol. 27:3894-3900(2009) · Mapped (18) |
| Mapping of human autoantibody binding sites on the calcium-sensing receptor. Kemp E.H., Gavalas N.G., Akhtar S., Krohn K.J., Pallais J.C., Brown E.M., Watson P.F., Weetman A.P. J. Bone Miner. Res. 25:132-140(2010) · Mapped (9) |
| Mapping of melanin-concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies. Gavalas N.G., Gottumukkala R.V., Gawkrodger D.J., Watson P.F., Weetman A.P., Kemp E.H. Exp. Dermatol. 18:454-463(2009) · Mapped (4) |
| Mitogen-activated protein kinase (MAPK) pathways mediate embryonic responses to culture medium osmolarity by regulating Aquaporin 3 and 9 expression and localization, as well as embryonic apoptosis. Bell C.E., Lariviere N.M., Watson P.H., Watson A.J. Hum. Reprod. 24:1373-1386(2009) · Mapped (5) |
| S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nott A., Watson P.M., Robinson J.D., Crepaldi L., Riccio A. |
| Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer. Wang J., Barnes R.O., West N.R., Olson M., Chu J.E., Watson P.H. Breast Cancer Res. 10:R51-R51(2008) · Mapped (79) |
| Epidermal growth factor receptor vIII expression in U87 glioblastoma cells alters their proteasome composition, function, and response to irradiation. Kim K., Brush J.M., Watson P.A., Cacalano N.A., Iwamoto K.S., McBride W.H. Mol. Cancer Res. 6:426-434(2008) · Mapped (26) |